Convergence of biomaterials and immunology: a technology platform for delayed burst release of vaccines

生物材料与免疫学的融合：疫苗延迟爆发释放的技术平台

• 批准号: DP120104611
• 负责人: Prof Dietmar W. Hutmacher
• 金额: $ 19.37万
• 依托单位: Queensland University of Technology
• 依托单位国家: 澳大利亚
• 项目类别: Discovery Projects
• 财政年份: 2012
• 资助国家: 澳大利亚
• 起止时间: 2012-01-01 至 2015-12-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/DP120104611
• 关键词: Convergence; biomaterials; immunology; technology; platform

A large challenge in vaccination, particularly in wildlife such as for the growing problem of Chlamydia in koalas, is to provide the necessary booster shots. This project will develop implants that will be inserted under the skin at the time of the first shot, and will spontaneously burst later to release the booster shot to provide protection.

疫苗接种的一大挑战，特别是在野生动物中，如日益严重的考拉衣原体问题，是提供必要的强化注射。该项目将开发植入物，这种植入物将在第一次注射时插入皮肤下，并在随后自发破裂，以释放助推器注射，以提供保护。